AstroNova Announces Fiscal Fourth-Quarter and Full-Year 2023 Financial Results
AstroNova, Inc. (Nasdaq: ALOT) reported strong results for the fourth quarter and full year ended January 31, 2023. Fourth-quarter bookings reached $36.3 million, with revenue of $39.9 million—a 34% year-over-year increase. Net income for the quarter was $1.4 million or $0.18 per diluted share. For the full year, the company achieved $142.5 million in revenue and net income of $2.7 million or $0.36 per diluted share, although this was a decline from the previous year. Both segments showed growth, especially Test & Measurement, which saw 61% revenue growth driven by aerospace products. The backlog stood at $35.8 million as of year-end.
- Fourth-quarter revenue increased 34% year-over-year to $39.9 million.
- Net income for the fourth quarter was $1.4 million, up from a loss of $0.8 million the previous year.
- Bookings for the full-year 2023 reached $138.6 million, an improvement from $128.6 million in fiscal 2022.
- Significant revenue growth in Test & Measurement segment, up 61% year-over-year.
- Full-year net income decreased from $6.4 million in fiscal 2022 to $2.7 million in fiscal 2023.
- Operating income margin declined from 11.5% in fiscal 2022 to 7.7% in fiscal 2023 for the Product Identification segment.
Company to Host Conference Call at
Fiscal Fourth-Quarter 2023 Summary
-
Bookings of
$36.3 million -
Revenue of
$39.9 million -
Operating income of
$2.1 million -
Net income of
, or$1.4 million per diluted share$0.18 -
Adjusted EBITDA of
, or$3.9 million 9.7% of revenue
Fiscal Full-Year 2023 Summary
-
Bookings of
$138.6 million -
Backlog of
at fiscal year-end$35.8 million -
Revenue of
$142.5 million -
Operating income of
$5.4 million -
Net income of
, or$2.7 million per diluted share$0.36 -
Adjusted EBITDA of
, or$10.3 million 7.3% of revenue
CEO Commentary
“We finished fiscal 2023 with a strong fourth quarter, delivering solid revenue and earnings growth,” stated
“Revenue increased
“Our Product Identification segment generated
“Looking ahead, we are well positioned in both of our segments, in Product Identification we are excited about the opportunities to continue to capitalize on the synergies provided by Astro Machine, and the rebound in the Aerospace and Defense sectors bodes well for our Test and Measurement segment, as we begin fiscal 2024,” Woods concluded. “Powered by the AstroNova Operating System, the foundation of our continuous improvement strategy, we expect sustained momentum throughout the year.”
On a Generally Accepted Accounting Principles (GAAP) basis, net income for the 12 months ended
Operating Segment Results
Product Identification
Product Identification segment revenue was
For fiscal full-year 2023, Product Identification revenue increased to
Test & Measurement
Test & Measurement segment revenue increased to
For fiscal full-year 2023, Test & Measurement revenue was
Financial Results Summary
Revenue totaled
Hardware revenue in the fourth quarter of fiscal 2023 was
Gross profit was
For fiscal 2023, gross profit was
Operating expenses totaled
Operating income was
Net income was
Earnings before interest, taxes, depreciation and amortization (EBITDA) was
Adjusted EBITDA, which the Company defines as earnings before interest, taxes, depreciation, amortization and share-based compensation, was
Bookings in the fourth quarter of fiscal 2023 were
Backlog as of
Earnings Conference Call
Use of Non-GAAP Financial Measures
In addition to financial measures prepared in accordance with generally accepted accounting principles (GAAP), this news release contains the non-GAAP financial measures non-GAAP gross profit excluding the employee retention credit under the CARES Act; non-GAAP operating expenses excluding Astro Machine acquisition costs; non-GAAP operating expenses excluding employee retention credit under the CARES Act; non-GAAP operating income excluding Astro Machine acquisition costs; non-GAAP operating income excluding employee retention credit under the CARES Act; non-GAAP net income and earnings per share, diluted, excluding Astro Machine acquisition costs; non-GAAP net income and earnings per share, diluted, excluding ERP write-off expense, employee retention credit under the CARES Act and PPP loan forgiveness; EBITDA and Adjusted EBITDA; EBITDA and Adjusted EBITDA excluding Astro Machine acquisition costs; EBITDA and Adjusted EBITDA excluding the ERP write-off expense, the employee retention credit under the CARES Act and the PPP loan forgiveness; and non-GAAP segment operating profit excluding the employee retention credit under the CARES Act.
About
Forward-Looking Statements
Information included in this news release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact, but rather reflect our current expectations concerning future events and results. These statements may include the use of the words “believes,” “expects,” “intends,” “plans,” “anticipates,” “likely,” “continues,” “may,” “will,” and similar expressions to identify forward-looking statements. Such forward-looking statements, including those concerning the Company’s anticipated performance, involve risks, uncertainties and other factors, some of which are beyond our control, which may cause our actual results, performance or achievements to be materially different from those expressed or implied by such forward-looking statements. These risks, uncertainties and factors include, but are not limited to, (i) the risk that we may not be able to realize the expected synergies from our acquisition of Astro Machine, (ii) the risk that apparent improvements in the Aerospace and Defense sectors may not continue and (iii) those factors set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended
Condensed Consolidated Statements of Income | ||||||||||||
In Thousands Except for Per Share Data | ||||||||||||
(Unaudited) | ||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||
Revenue | $ |
39,853 |
$ |
29,700 |
$ |
142,527 |
$ |
117,480 |
||||
Cost of Revenue |
|
26,291 |
|
19,949 |
|
94,371 |
|
73,741 |
||||
Gross Profit |
|
13,562 |
|
9,751 |
|
48,156 |
|
43,739 |
||||
Total Gross Profit Margin |
|
|
|
|
|
|
|
|
||||
Operating Expenses: | ||||||||||||
Selling & Marketing |
|
6,686 |
|
6,247 |
|
24,456 |
|
23,177 |
||||
Research & Development |
|
1,801 |
|
1,549 |
|
6,822 |
|
6,753 |
||||
General & Administrative |
|
2,978 |
|
2,182 |
|
11,435 |
|
9,553 |
||||
Total Operating Expenses |
|
11,465 |
|
9,978 |
|
42,713 |
|
39,483 |
||||
Operating Income |
|
2,097 |
|
(227) |
|
5,443 |
|
4,256 |
||||
Total Operating Margin |
|
|
|
- |
|
|
|
|
||||
Other Income (Expense), net: | ||||||||||||
Interest Expense |
|
(592) |
|
(150) |
|
(1,678) |
|
(677) |
||||
Gain (Loss) on Foreign Currency Transactions |
|
140 |
|
(57) |
|
(474) |
|
(288) |
||||
Gain on Extinguishment of Debt - PPP Loan |
|
- |
|
- |
|
- |
|
4,466 |
||||
Loss on Disposal of Assets |
|
- |
|
- |
|
- |
|
(696) |
||||
Other, net |
|
85 |
|
(17) |
|
119 |
|
(27) |
||||
|
(367) |
|
(224) |
|
(2,033) |
|
2,778 |
|||||
Income (Loss) Before Taxes |
|
1,730 |
|
(451) |
|
3,410 |
|
7,034 |
||||
Income Tax Provision |
|
367 |
|
308 |
|
749 |
|
605 |
||||
Net Income (Loss) | $ |
1,363 |
$ |
(759) |
$ |
2,661 |
$ |
6,429 |
||||
Net Income (Loss) per Common Share - Basic | $ |
0.19 |
$ |
(0.10) |
$ |
0.36 |
$ |
0.89 |
||||
Net Income (Loss) per Common Share - Diluted | $ |
0.18 |
$ |
(0.10) |
$ |
0.36 |
$ |
0.88 |
||||
Weighted Average Number of Common Shares - Basic |
|
7,330 |
|
7,237 |
|
7,307 |
|
7,207 |
||||
Weighted Average Number of Common Shares - Diluted |
|
7,406 |
|
7,237 |
|
7,374 |
|
7,339 |
||||
Balance Sheet | |||||
In Thousands | |||||
(Unaudited) | |||||
ASSETS | |||||
CURRENT ASSETS | |||||
Cash and Cash Equivalents | $ |
3,946 |
$ |
5,276 |
|
Accounts Receivable, net |
|
21,598 |
|
17,124 |
|
Inventories, net |
|
51,324 |
|
34,609 |
|
Employee Retention Credit Receivable |
|
- |
|
3,135 |
|
Prepaid Expenses and Other Current Assets |
|
2,894 |
|
3,634 |
|
Total Current Assets |
|
79,762 |
|
63,778 |
|
PROPERTY, PLANT AND EQUIPMENT |
|
55,394 |
|
50,821 |
|
Less Accumulated Depreciation |
|
(41,106) |
|
(39,380) |
|
Property, Plant and Equipment, net |
|
14,288 |
|
11,441 |
|
OTHER ASSETS | |||||
Intangible Assets, net |
|
20,702 |
|
19,200 |
|
|
14,658 |
|
12,156 |
||
Deferred Tax Assets |
|
6,740 |
|
5,591 |
|
Right of Use Asset |
|
794 |
|
1,094 |
|
Other Assets |
|
1,566 |
|
1,695 |
|
TOTAL ASSETS | $ |
138,510 |
$ |
114,955 |
|
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||
CURRENT LIABILITIES | |||||
Accounts Payable | $ |
8,617 |
$ |
8,590 |
|
Accrued Compensation |
|
2,750 |
|
3,512 |
|
Other Liabilities and Accrued Expenses |
|
3,337 |
|
4,113 |
|
Revolving Line of Credit |
|
15,900 |
|
- |
|
Current Portion of Royalty Obligation |
|
2,100 |
|
2,000 |
|
Current Portion of Long-Term Debt |
|
1,625 |
|
1,000 |
|
Current Liability – Excess Royalty Payment Due |
|
423 |
|
235 |
|
Income Taxes Payable |
|
786 |
|
323 |
|
Deferred Revenue |
|
1,860 |
|
262 |
|
Total Current Liabilities |
|
37,398 |
|
20,035 |
|
NON-CURRENT LIABILITIES | |||||
Long-Term Debt, net of current portion |
|
12,040 |
|
8,154 |
|
Royalty Obligation, net of current portion |
|
2,985 |
|
4,361 |
|
Lease Liability, net of current portion |
|
555 |
|
808 |
|
Income Taxes Payable |
|
491 |
|
399 |
|
Deferred Income |
|
674 |
|
- |
|
Deferred Tax Liabilities |
|
- |
|
186 |
|
TOTAL LIABILITIES |
|
54,143 |
|
33,943 |
|
SHAREHOLDERS’ EQUITY | |||||
Common Stock |
|
534 |
|
528 |
|
|
61,131 |
|
59,692 |
||
Retained Earnings |
|
59,175 |
|
56,514 |
|
Treasury Stock |
|
(34,235) |
|
(33,974) |
|
Accumulated Other Comprehensive Loss, net of tax |
|
(2,238) |
|
(1,748) |
|
TOTAL SHAREHOLDERS’ EQUITY |
|
84,367 |
|
81,012 |
|
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ |
138,510 |
$ |
114,955 |
|
Revenue and Segment Operating Profit (Loss) | |||||||||||||||||
In Thousands | |||||||||||||||||
(Unaudited) | |||||||||||||||||
Revenue | Segment Operating Profit (Loss) | Revenue | Segment Operating Profit (Loss) | ||||||||||||||
Three Months Ended | Three Months Ended | Twelve Months Ended | Twelve Months Ended | ||||||||||||||
Product Identification | $ |
28,105 |
$ |
22,396 |
$ |
1,869 |
$ |
1,460 |
$ |
103,089 |
$ |
90,915 |
$ |
7,889 |
$ |
10,411 |
|
Test & Measurement |
|
11,748 |
|
7,304 |
|
3,206 |
|
495 |
|
39,438 |
|
26,565 |
|
8,989 |
|
3,398 |
|
Total | $ |
39,853 |
$ |
29,700 |
|
5,075 |
|
1,955 |
$ |
142,527 |
$ |
117,480 |
|
16,878 |
|
13,809 |
|
Corporate Expenses |
|
2,978 |
|
2,182 |
|
11,435 |
|
9,553 |
|||||||||
Operating Income |
|
2,097 |
|
(227) |
|
5,443 |
|
4,256 |
|||||||||
Other Income (Expense), net |
|
(367) |
|
(224) |
|
(2,033) |
|
2,778 |
|||||||||
Income (Loss) Before Income Taxes |
|
1,730 |
|
(451) |
|
3,410 |
|
7,034 |
|||||||||
Income Tax Provision |
|
367 |
|
308 |
|
749 |
|
605 |
|||||||||
Net Income (Loss) | $ |
1,363 |
$ |
(759) |
$ |
2,661 |
$ |
6,429 |
|||||||||
Reconciliation of GAAP to Non-GAAP - Gross Profit | |||||||||||
Amounts in Thousands | |||||||||||
(Unaudited) | |||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||
Gross Profit − GAAP | $ |
13,562 |
$ |
9,751 |
$ |
48,156 |
$ |
43,739 |
|||
Employee Retention Credit, net |
|
- |
|
- |
|
- |
|
(1,641) |
|||
Gross Profit − Non-GAAP | $ |
13,562 |
$ |
9,751 |
$ |
48,156 |
$ |
42,098 |
|||
Reconciliation of GAAP to Non-GAAP - Operating Expenses | |||||||||||
Amounts in Thousands | |||||||||||
(Unaudited) | |||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||
Operating Expenses − GAAP | $ |
11,465 |
$ |
9,978 |
$ |
42,713 |
$ |
39,483 |
|||
Transaction Costs | $ |
- |
$ |
- |
$ |
(716) |
$ |
- |
|||
Employee Retention Credit, net |
|
- |
|
- |
|
- |
|
489 |
|||
Operating Expenses − Non-GAAP | $ |
11,465 |
$ |
9,978 |
$ |
41,997 |
$ |
39,972 |
|||
Reconciliation of GAAP to Non-GAAP - Operating Income (Loss) | |||||||||||
Amounts in Thousands | |||||||||||
(Unaudited) | |||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||
Operating Income − GAAP | $ |
2,097 |
$ |
(227) |
$ |
5,443 |
$ |
4,256 |
|||
Transaction Costs | $ |
- |
$ |
- |
$ |
716 |
$ |
- |
|||
Employee Retention Credit, net |
|
- |
|
- |
|
- |
|
(2,130) |
|||
Operating Income − Non-GAAP | $ |
2,097 |
$ |
(227) |
$ |
6,159 |
$ |
2,126 |
|||
Reconciliation of GAAP to Non-GAAP - Net Income (Loss) | |||||||||||
Amounts in Thousands | |||||||||||
(Unaudited) | |||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||
Net Income (Loss) − GAAP | $ |
1,363 |
$ |
(759) |
$ |
2,661 |
$ |
6,429 |
|||
Transaction Costs |
|
- |
|
- |
|
540 |
|
- |
|||
Oracle EnterpriseOne ERP Write-off |
|
- |
|
- |
|
- |
|
528 |
|||
Employee Retention Credit, net |
|
- |
|
- |
|
- |
|
(1,615) |
|||
PPP Loan Forgiveness |
|
- |
|
- |
|
- |
|
(4,426) |
|||
Net Income (Loss) − Non-GAAP | $ |
1,363 |
$ |
(759) |
$ |
3,201 |
$ |
916 |
|||
Reconciliation of GAAP to Non-GAAP - Diluted Earnings Per Share | |||||||||||
(Unaudited) | |||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||
Diluted Earnings Per Share − GAAP | $ |
0.18 |
$ |
(0.10) |
$ |
0.36 |
$ |
0.88 |
|||
Transaction Costs |
|
- |
|
- |
|
0.07 |
|
- |
|||
Oracle EnterpriseOne ERP Write-off |
|
- |
|
- |
|
- |
|
0.07 |
|||
Employee Retention Credit, net |
|
- |
|
- |
|
- |
|
(0.22) |
|||
PPP Loan Forgiveness |
|
- |
|
- |
|
- |
|
(0.60) |
|||
Diluted Earnings Per Share − Non-GAAP | $ |
0.18 |
$ |
(0.10) |
$ |
0.43 |
$ |
0.12 |
|||
Reconciliation of Net Income (Loss) to EBITDA | |||||||||||
Amounts in Thousands | |||||||||||
(Unaudited) | |||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||
Net Income (Loss) − GAAP | $ |
1,363 |
$ |
(759) |
$ |
2,661 |
$ |
6,429 |
|||
Interest Expense |
|
592 |
|
150 |
|
1,678 |
|
675 |
|||
Income Tax Expense (Provision) |
|
367 |
|
308 |
|
749 |
|
605 |
|||
Depreciation/Amortization |
|
1,223 |
|
926 |
|
3,960 |
|
3,996 |
|||
EBITDA | $ |
3,545 |
$ |
625 |
$ |
9,048 |
$ |
11,705 |
|||
Net Income - Employee Retention Credit |
|
- |
|
- |
|
- |
|
(1,615) |
|||
Net Income - PPP Loan Forgiveness |
|
- |
|
- |
|
- |
|
(4,426) |
|||
Net Income - Oracle EnterpriseOne ERP Write-off |
|
- |
|
- |
|
- |
|
528 |
|||
Net Income - Transaction Costs |
|
- |
|
- |
|
540 |
|
- |
|||
Income Tax Expense - Employee Retention Credit |
|
- |
|
- |
|
- |
|
(515) |
|||
Income Tax Expense - PPP Loan Forgiveness |
|
- |
|
- |
|
- |
|
(40) |
|||
Income Tax Expense - Oracle EnterpriseOne ERP Write-off |
|
- |
|
- |
|
168 |
|||||
Income Tax Expense - Transaction Costs |
|
- |
|
- |
|
176 |
|
- |
|||
EBITDA | $ |
3,545 |
$ |
625 |
$ |
9,764 |
$ |
5,805 |
|||
Reconciliation of Net Income (Loss) to Adjusted EBITDA | |||||||||||
Amounts in Thousands | |||||||||||
(Unaudited) | |||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||
Net Income (Loss) − GAAP | $ |
1,363 |
$ |
(759) |
$ |
2,661 |
$ |
6,429 |
|||
Interest Expense |
|
592 |
|
150 |
|
1,678 |
|
675 |
|||
Income Tax (Provision) Expense |
|
367 |
|
308 |
|
749 |
|
605 |
|||
Depreciation/Amortization |
|
1,223 |
|
926 |
|
3,960 |
|
3,996 |
|||
Share-Based Compensation |
|
314 |
|
148 |
|
1,291 |
|
1,493 |
|||
Adjusted EBITDA | $ |
3,859 |
$ |
773 |
$ |
10,339 |
$ |
13,198 |
|||
Net Income - Employee Retention Credit |
|
- |
|
- |
|
- |
|
(1,615) |
|||
Net Income - PPP Loan Forgiveness |
|
- |
|
- |
|
- |
|
(4,426) |
|||
Net Income - Oracle EnterpriseOne ERP Write-off |
|
- |
|
- |
|
- |
|
528 |
|||
Net Income - Transaction Costs |
|
- |
|
- |
|
540 |
|
- |
|||
Income Tax Expense - Employee Retention Credit |
|
- |
|
- |
|
- |
|
(515) |
|||
Income Tax Expense - PPP Loan Forgiveness |
|
- |
|
- |
|
- |
|
(40) |
|||
Income Tax Expense - Oracle EnterpriseOne ERP Write-off |
|
- |
|
- |
|
- |
|
168 |
|||
Income Tax Expense - Transaction Costs |
|
- |
|
- |
|
176 |
|
- |
|||
Adjusted EBITDA | $ |
3,859 |
$ |
773 |
$ |
11,055 |
$ |
7,298 |
|||
Reconciliation of Segment GAAP to Non-GAAP Operating Income (Loss) | |||||||||||||||||||||||||||
Amounts in Thousands | |||||||||||||||||||||||||||
(Unaudited) | |||||||||||||||||||||||||||
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||||||
Product Identification | Test & Measurement | Total | Product Identification | Test & Measurement | Total | Product Identification | Test & Measurement | Total | Product Identification | Test & Measurement | Total | ||||||||||||||||
Segment Operating Profit (Loss) - GAAP | $ |
1,869 |
$ |
3,206 |
$ |
5,075 |
$ |
1,460 |
$ |
495 |
$ |
1,955 |
$ |
7,889 |
$ |
8,989 |
$ |
16,878 |
$ |
10,411 |
$ |
3,398 |
$ |
13,809 |
|||
Employee Retention Credit, net |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
- |
|
(1,430) |
|
(802) |
|
(2,232) |
|||
Segment Operating Profit - Non-GAAP | $ |
1,869 |
$ |
3,206 |
$ |
5,075 |
$ |
1,460 |
$ |
495 |
$ |
1,955 |
$ |
7,889 |
$ |
8,989 |
$ |
16,878 |
$ |
8,982 |
$ |
2,596 |
$ |
11,578 |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230322005749/en/
Senior Vice President
(857) 383-2409
ALOT@investorrelations.com
Source:
FAQ
What were AstroNova's earnings results for fourth quarter 2023?
What was the full-year revenue for AstroNova in fiscal 2023?
What are AstroNova's bookings for fiscal year 2023?